Opioid Overdose

In this episode, guest Cammie Wolf Rice discusses the opioid crisis, how it impacted her life and family and her foundation’s mission to combating the epidemic and spreading awareness.

Fentanyl-involved overdose mortality rates were disproportionately high among American Indian or Alaska Native and Black individuals compared with other racial and ethnic groups, according to a research letter published in JAMA Psychiatry.

Although state laws have expanded access to naloxone, overdose deaths among adolescents and young adults continue to climb, according to data published in JAMA Pediatrics.

A community coalition-engaged intervention led to a statistically significant reduction in overdose deaths involving any opioid and psychostimulants other than cocaine, according to a study published in JAMA Network Open.

Adults with type 2 diabetes and opioid use disorder who received semaglutide had significantly lower risk for opioid overdose compared with those taking other diabetes medications, a research letter in JAMA Network Open showed.

Aug. 31 is International Overdose Awareness Day. It is a time to remember those lost to substance use disorders and addiction, particularly as the United States and countries around the globe grapple with the opioid crisis.

The FDA approved Zurnai, the first nalmefene hydrochloride auto-injector, for emergency treatment of opioid overdose in adults and youth aged 12 years and older.

SAN FRANCISCO — Socioeconomic and sociodemographic factors are associated with opioid overdose in pregnant and postpartum women, highlighting the need for more research, drug screening and judgment-free services for those at high risk.

Less than 15% of surveyed U.S. college students knew how to use naloxone in the event of an overdose, according to results published in JAMA Pediatrics.

The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.